Novelix Pharmaceuticals Ltd.

Financial

	Novelix Pharma	Dipna Pharma.	Binny Mills
Operational Metrics
Financials
5 yr Average ROE	-17.5 %	16.1 %	2.38 %
5yr average Equity Multiplier	1.26	14.87	-1.02
5yr Average Asset Turnover Ratio	0.84	1.35	0.04
5yr Avg Net Profit Margin	-14.11 %	0.81 %	-67.35 %
Price to Book	8.06	1.38	0.0
P/E	102.3	53.91	0.0
5yr Avg Cash Conversion Cycle	29.1 Days	-33.62 Days	15.76 Days
Inventory Days	34.04 Days	62.45 Days	84.09 Days
Days Receivable	55.38 Days	112.8 Days	20.05 Days
Days Payable	55.7 Days	139.84 Days	129.33 Days
5yr Average Interest Coverage Ratio	-17.77	2.01	0.6
5yr Avg ROCE	-15.4 %	12.33 %	-152.87 %
5yr Avg Operating Profit Margin	-16.49 %	2.41 %	5.31 %
5 yr average Debt to Equity	0.05	5.84	-0.82
5yr CAGR Net Profit	35.78 %	117.34 %	n/a
5yr Average Return on Assets	-13.36 %	1.21 %	-3.02 %
Shareholdings
Promoter Holding	52.75 %	9.98 %	68.97 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-14.17 %	-56.58 %	-5.89 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0